FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2073080260> ?p ?o ?g. }

• W2073080260 endingPage "2283" @default.
• W2073080260 startingPage "2274" @default.
• W2073080260 abstract "The large numbers of partial clozapine responders represent a major therapeutic challenge. Unfortunately, there are no clear data to support how best to treat these patients. This study examines the efficacy and safety of adjunctive risperidone in a well-defined treatment-resistant population optimally treated with clozapine. A total of 69 inpatients and outpatients with DSM-IV schizophrenia or schizoaffective disorder entered a 16-week double-blind, placebo-controlled, randomized clinical trial. Of them, 33 participants were randomized to risperidone and 36 were randomized to placebo. There was no significant group difference in the predefined response criteria. There were modest group differences for Brief Psychiatric Rating Scale (BPRS) positive symptoms, which were significant in the completer analysis (F=5.70; df=1, 70.3; p=0.02; ES=0.27) but not the intent-to-treat (ITT) analyses (F=3.01; df=1, 77.5; p=0.09; ES=0.19). A similar pattern was found for the BPRS total score, with the completer analysis showing a significant improvement in the risperidone group (F=5.21; df=1, 64.9; p=0.03; ES=0.27), whereas the ITT analysis was not significant (F=3.52; df=1, 71.3; p=0.06; ES=0.22). In addition, there was a small, but significant, group difference for negative symptoms, as measured by the SANS total score, which favored the risperidone group (F=5.67; df=1, 78.7; p=0.02; ES=0.24). There were no significant group differences on safety measures, including neuropsychological test and extrapyramidal symptom scores. A significant elevation of prolactin in the risperidone group was observed. The study results suggest that adjunctive risperidone may have a modest benefit for treatment-resistant clozapine patients. The study results are discussed in the context of previous double-blind studies of adjunctive risperidone. (clinicaltrials.gov, trial number: NCT00056498)." @default.
• W2073080260 created "2016-06-24" @default.
• W2073080260 creator A5018010521 @default.
• W2073080260 creator A5028131133 @default.
• W2073080260 creator A5045314404 @default.
• W2073080260 creator A5046858731 @default.
• W2073080260 creator A5070223359 @default.
• W2073080260 creator A5071536045 @default.
• W2073080260 creator A5074412924 @default.
• W2073080260 creator A5075611077 @default.
• W2073080260 creator A5077670489 @default.
• W2073080260 date "2010-07-21" @default.
• W2073080260 modified "2023-10-17" @default.
• W2073080260 title "Adjunctive Risperidone for Partially Responsive People with Schizophrenia Treated with Clozapine" @default.
• W2073080260 cites W1973840419 @default.
• W2073080260 cites W1975699010 @default.
• W2073080260 cites W1976741101 @default.
• W2073080260 cites W1999689270 @default.
• W2073080260 cites W2000555003 @default.
• W2073080260 cites W2004423661 @default.
• W2073080260 cites W2011505534 @default.
• W2073080260 cites W2018317330 @default.
• W2073080260 cites W2020844317 @default.
• W2073080260 cites W2021968198 @default.
• W2073080260 cites W2040764030 @default.
• W2073080260 cites W2054228210 @default.
• W2073080260 cites W2062571521 @default.
• W2073080260 cites W2078096127 @default.
• W2073080260 cites W2082959963 @default.
• W2073080260 cites W2083680124 @default.
• W2073080260 cites W2085360366 @default.
• W2073080260 cites W2086503579 @default.
• W2073080260 cites W2096542244 @default.
• W2073080260 cites W2107625293 @default.
• W2073080260 cites W2109187468 @default.
• W2073080260 cites W2110091980 @default.
• W2073080260 cites W2123636908 @default.
• W2073080260 cites W2126132542 @default.
• W2073080260 cites W2127772714 @default.
• W2073080260 cites W2129116806 @default.
• W2073080260 cites W2142670205 @default.
• W2073080260 cites W2149860264 @default.
• W2073080260 cites W2165379748 @default.
• W2073080260 cites W2166158209 @default.
• W2073080260 cites W2166977877 @default.
• W2073080260 cites W2168362300 @default.
• W2073080260 cites W2329708303 @default.
• W2073080260 cites W2333571283 @default.
• W2073080260 cites W4232804908 @default.
• W2073080260 cites W4236221104 @default.
• W2073080260 cites W58194748 @default.
• W2073080260 cites W59918674 @default.
• W2073080260 cites W92311904 @default.
• W2073080260 cites W1966713366 @default.
• W2073080260 doi "https://doi.org/10.1038/npp.2010.101" @default.
• W2073080260 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2939921" @default.
• W2073080260 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20664583" @default.
• W2073080260 hasPublicationYear "2010" @default.
• W2073080260 type Work @default.
• W2073080260 sameAs 2073080260 @default.
• W2073080260 citedByCount "48" @default.
• W2073080260 countsByYear W20730802602012 @default.
• W2073080260 countsByYear W20730802602013 @default.
• W2073080260 countsByYear W20730802602014 @default.
• W2073080260 countsByYear W20730802602016 @default.
• W2073080260 countsByYear W20730802602017 @default.
• W2073080260 countsByYear W20730802602018 @default.
• W2073080260 countsByYear W20730802602019 @default.
• W2073080260 countsByYear W20730802602020 @default.
• W2073080260 countsByYear W20730802602021 @default.
• W2073080260 countsByYear W20730802602022 @default.
• W2073080260 crossrefType "journal-article" @default.
• W2073080260 hasAuthorship W2073080260A5018010521 @default.
• W2073080260 hasAuthorship W2073080260A5028131133 @default.
• W2073080260 hasAuthorship W2073080260A5045314404 @default.
• W2073080260 hasAuthorship W2073080260A5046858731 @default.
• W2073080260 hasAuthorship W2073080260A5070223359 @default.
• W2073080260 hasAuthorship W2073080260A5071536045 @default.
• W2073080260 hasAuthorship W2073080260A5074412924 @default.
• W2073080260 hasAuthorship W2073080260A5075611077 @default.
• W2073080260 hasAuthorship W2073080260A5077670489 @default.
• W2073080260 hasBestOaLocation W20730802601 @default.
• W2073080260 hasConcept C118552586 @default.
• W2073080260 hasConcept C126322002 @default.
• W2073080260 hasConcept C142724271 @default.
• W2073080260 hasConcept C15744967 @default.
• W2073080260 hasConcept C168563851 @default.
• W2073080260 hasConcept C204787440 @default.
• W2073080260 hasConcept C27081682 @default.
• W2073080260 hasConcept C2776412080 @default.
• W2073080260 hasConcept C2778528637 @default.
• W2073080260 hasConcept C2779727114 @default.
• W2073080260 hasConcept C2780057945 @default.
• W2073080260 hasConcept C2780325297 @default.
• W2073080260 hasConcept C2780864610 @default.
• W2073080260 hasConcept C71924100 @default.
• W2073080260 hasConceptScore W2073080260C118552586 @default.
• W2073080260 hasConceptScore W2073080260C126322002 @default.

• next